Milestone Scientific, Inc. (OTCPK:MLSS) insiders have most recently took part in a trading activity. On Jun 29, 2016 Bp4 S.r.l., See Remarks, 10% Owner bought 1,000,000 shares having total worth of $2,000,000 at the price of $2 per share, following the transaction a total of 3,000,000 shares owned by Bp4 S.r.l..
On the same day, Trombetta Giandomenico, See Remarks, 10% Owner bought 1,000,000 shares having total worth of $2,000,000 at the price of $2 per share, following the transaction a total of 3,066,390 shares owned by Trombetta Giandomenico.
Shares of Milestone Scientific, Inc. (OTCPK:MLSS) traded up 4.81% on Jun 29, 2016, hitting $2.83. 81,700 shares of the company’s stock traded hands. Milestone Scientific, Inc. has a 52 week low of $1.27 and a 52 week high of $4. The company’s market cap is $61 million.
Milestone Scientific, Inc. (OTCPK:MLSS) last announced its earnings results on May 17, 2016. The company reported -0.03 earnings per share (EPS) for the quarter, lower than the consensus estimate of -0.01 by $0.02. The company had revenue of $4 million for the quarter, compared to the consensus estimate of $3 million. During the same quarter in the previous year, the company posted -0.02 earnings per share. The company’s revenue for the quarter was up 29% on a year-over-year basis.
|earnings per share||-0.03||-0.07||-0.07||-0.09||-0.02|
Milestone Scientific, Inc. was incorporated in the State of Delaware in August 1989. The Company is engaged in pioneering proprietary, innovative technological systems and solutions for the medical and dental markets. From its inception, the Company has focused its energy and resources on redefining the global standard of care for injection techniques by making the experience more comfortable for the patient and by reducing the anxiety and stress of giving injections for the healthcare provider. The Company expanded its product offerings with the introduction of the CompuMed advanced injection system, designed for use in a range of applications within the Medical industry, including cosmetic surgery, hair restoration surgery, podiatry, colorectal surgery, nasal and sinus surgery, dermatology and orthopedics, among others. Milestone has developed and brought to market a differentiated portfolio of industry innovations. Thus the Company’s proprietary solutions have succeeded in elevating the standard of care in the professional dental arena. The product portfolio includes: STA Single Tooth Anesthesia System (STA System), CompuDent, CompuMed, The Wand and The SafetyWand. Milestone’s proprietary, patented Computer-Controlled Local Anesthesia Delivery (C-CLAD) systems compete with disposable and reusable syringes that generally sell at lower prices and that use established and well-understood methodologies in both the dental and medical marketplaces. The manufacture and sale of medical devices and other medical products are subject to extensive regulation by the FDA pursuant to the FDC Act, and by other federal, state and foreign authorities.
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018